Anti-A2AP/ SERPINF2/ AAP functional antibody

Anti-A2AP/ SERPINF2/ AAP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SERPINF2/SERPINF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1282-Ab-1/ GM-Tg-hg-SE1282-Ab-2Anti-Human SERPINF2 monoclonal antibodyHuman
GM-Tg-rg-SE1282-Ab-1/ GM-Tg-rg-SE1282-Ab-2Anti-Rat SERPINF2 monoclonal antibodyRat
GM-Tg-mg-SE1282-Ab-1/ GM-Tg-mg-SE1282-Ab-2Anti-Mouse SERPINF2 monoclonal antibodyMouse
GM-Tg-cynog-SE1282-Ab-1/ GM-Tg-cynog-SE1282-Ab-2Anti-Cynomolgus/ Rhesus macaque SERPINF2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1282-Ab-1/ GM-Tg-felg-SE1282-Ab-2Anti-Feline SERPINF2 monoclonal antibodyFeline
GM-Tg-cang-SE1282-Ab-1/ GM-Tg-cang-SE1282-Ab-2Anti-Canine SERPINF2 monoclonal antibodyCanine
GM-Tg-bovg-SE1282-Ab-1/ GM-Tg-bovg-SE1282-Ab-2Anti-Bovine SERPINF2 monoclonal antibodyBovine
GM-Tg-equg-SE1282-Ab-1/ GM-Tg-equg-SE1282-Ab-2Anti-Equine SERPINF2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1282-Ab-1/ GM-Tg-hg-SE1282-Ab-2; GM-Tg-rg-SE1282-Ab-1/ GM-Tg-rg-SE1282-Ab-2;
GM-Tg-mg-SE1282-Ab-1/ GM-Tg-mg-SE1282-Ab-2; GM-Tg-cynog-SE1282-Ab-1/ GM-Tg-cynog-SE1282-Ab-2;
GM-Tg-felg-SE1282-Ab-1/ GM-Tg-felg-SE1282-Ab-2; GM-Tg-cang-SE1282-Ab-1/ GM-Tg-cang-SE1282-Ab-2;
GM-Tg-bovg-SE1282-Ab-1/ GM-Tg-bovg-SE1282-Ab-2; GM-Tg-equg-SE1282-Ab-1/ GM-Tg-equg-SE1282-Ab-2
Products NameAnti-SERPINF2 monoclonal antibody
Formatmab
Target NameSERPINF2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SERPINF2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1282-Ag-1Recombinant multi-species A2AP/ SERPINF2/ AAP protein


    Target information

    Target IDGM-SE1282
    Target NameSERPINF2
    Gene ID5345,18816,287527,100427699,611266,101100166,282522,100060087
    Gene Symbol and SynonymsA2AP,AAP,ALPHA-2-PI,alpha2AP,API,PLI,Serpimf2,SERPINF2
    Uniprot AccessionP08697,P28800
    Uniprot Entry NameA2AP_HUMAN,A2AP_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167711
    Target ClassificationN/A

    The target: SERPINF2, gene name: SERPINF2, also named as A2AP, AAP, ALPHA-2-PI, API, PLI. This gene encodes a member of the serpin family of serine protease inhibitors. The protein is a major inhibitor of plasmin, which degrades fibrin and various other proteins. Consequently, the proper function of this gene has a major role in regulating the blood clotting pathway. Mutations in this gene result in alpha-2-plasmin inhibitor deficiency, which is characterized by severe hemorrhagic diathesis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.